To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06072131
Title To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL (CRESCENDO)
Acronym CRESCENDO
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Acrotech Biopharma Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | HUN | ESP